AIG
ATHE

American International Group’s Alterity Therapeutics ATHE Stock Holding History

American International Group’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-42
Closed -$1K – 3138
2016
Q1 		$1K Hold
42
– – ﹤0.01% 4932
2015
Q4 		$2K Hold
42
– – ﹤0.01% 4824
2015
Q3 		$2K Hold
42
– – ﹤0.01% 4803
2015
Q2 		$2.92K Hold
42
– – ﹤0.01% 4845
2015
Q1 		$2.8K Hold
42
– – ﹤0.01% 4794
2014
Q4 		$4.1K Hold
42
– – ﹤0.01% 4726
2014
Q3 		$5.35K Hold
42
– – ﹤0.01% 4682
2014
Q2 		$5.66K Sell
42
-53
-56% -$6.04K ﹤0.01% 4626
2014
Q1 		$16K Buy
+95
New +$52.5K ﹤0.01% 4266

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

American International Group's ATHE Position: Q2 2016 in Review

American International Group sold out of Alterity Therapeutics (ATHE) in Q2 2016, closing a stake of 42 shares — an estimated $1K sold.

American International Group first reported a position in ATHE in Q1 2014 and held it in 9 quarters. The position peaked at $16K in Q1 2014. 13 funds tracked by Wall St. Rank hold ATHE as of Q2 2016.

  • American International Group reported no remaining Alterity Therapeutics position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 42 Alterity Therapeutics shares in Q2 2016, an estimated $1K.
  • American International Group first reported a position in Alterity Therapeutics in Q1 2014 and held it in 9 quarters.
  • American International Group's Alterity Therapeutics position peaked at $16K in Q1 2014.
  • 13 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.